Skip to content
Screener

Veracyte VCYT Product revenue — Cost of Revenue

Other product segments

Testing revenue
$33.31M+17.9%

Similar metrics at other companies

Dell Technologies logo
DELLProduct — Cost of Revenue
$32.85B+117%
Designer Brands logo
DBIProduct — Cost of Revenue
$381.03M-2.9%
Service Corporation International logo
SCIProduct — Cost of Revenue
$284.08M+3.0%
Deluxe logo
DLXProduct — Cost of Revenue
$86.1M-17.8%
Bloom Energy logo
BEProduct — Cost of Revenue
$593.96M+199%
BridgeBio Pharma logo
BBIONet product revenue — Cost of Revenue
$7.73M+280%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$3.71B+97.6%
Enterprise value$3.48B+104%
P/E42.2×-29.1×
P/S6.9×+2.9×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Veracyte’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 8:07 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001384101-26-000031
Line itemThree Months Ended March 31, 20262025
Total revenue139,071114,473
Cost of revenue:
Cost of testing revenue33,30628,260
Cost of product revenue1,8911,422
Cost of biopharmaceutical and other revenue82,698
Intangible asset amortization - cost of revenue2,7072,585
Total cost of revenue37,91234,965
Gross profit101,15979,508

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Veracyte's product revenue — cost of revenue?
Veracyte (VCYT) reported product revenue — cost of revenue of $1.89M in Q1 2026.
How has Veracyte's product revenue — cost of revenue changed year-over-year?
Veracyte's product revenue — cost of revenue increased by 33.0% year-over-year, from $1.42M to $1.89M.
What is the long-term trend for Veracyte's product revenue — cost of revenue?
Over 4 years (2021 to 2025), Veracyte's product revenue — cost of revenue has grown at a 10.6% compound annual growth rate (CAGR), from $5.89M to $8.81M.
What does product revenue — cost of revenue mean?
This metric captures the direct costs incurred to produce and deliver the products sold within the specific business segment. It includes expenses such as raw materials, direct labor, and manufacturing overhead directly attributable to product revenue. Monitoring this cost is essential for assessing the segment's gross margin and operational efficiency.

Ask your AI about Veracyte's product revenue — cost of revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude